https://doi.org/10.4081/hmr.v1i5.252

Treatment of ebv-associated lymphomas in hiv

Vol. 1 No. 5: International Symposium on Infection-Driven Lymphomas, Rome, April 17-19, 2005
Published: May 29, 2009
Abstract Views: 257
Untitled (): 0
PDF: 221
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Andrea Antinori
support@pagepress.org
Lucia Fratino
The relationship between immunodeficiency and the increased frequency of non-Hodgkin lymphoma (NHL) was firstly noted nearly 35 years ago among transplanted patient, but it became more evident with the emergence of the human immunodeficiency virus (HIV) epidemic in the early 80’s.1 Since then, several epidemiological studies have assessed that HIV-infected individuals have 10 to 100-fold increased risks particularly for three types of NHL [i.e., primary central nervous system lymphoma (PCNSL); immunoblastic lymphoma and Burkitt’s lymphoma (BL)]. The clinico-pathological spectrum of AIDS-related NHLs includes: 1) BL and BL like lymphomas; 2) diffuse large B cell lymphoma (DLBCL) with immunoblastic features; 3) primary central nervous system lymphoma (PCNSL); and 4) two novel and rare entities, primary effusion lymphoma (PEL) and plasmablastic lymphoma of the oral cavity. Hodgkin’s disease (HD), is also seen with a higher frequency in HIV-infected persons,2 but it is not included among AIDS–defining conditions.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Antinori, A., & Fratino, L. (2009). Treatment of ebv-associated lymphomas in hiv. Hematology Meeting Reports (formerly Haematologica Reports), 1(5). https://doi.org/10.4081/hmr.v1i5.252
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).